Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Pathology & Oncology Research
Published in: Pathology & Oncology Research 2/2019

01-04-2019 | Letter to the Editor

Genetic Analysis of Brazilian Patients with Gallbladder Cancer

Authors: Cristina Sábato, Luciana Bastos-Rodrigues, Debora Chaves Moraes, Eitan Friedman, Luiz De Marco, Vivian Resende

Published in: Pathology & Oncology Research | Issue 2/2019

Login to get access

Excerpt

To the Editor, …
Literature
1.
Bal MM, Ramadwar M, Deodhar K, Shrikhande S (2015) Pathology of gallbladder carcinoma: current understanding and new perspectives. Pathol. Oncol. Res. 21:509–525CrossRefPubMed
2.
Jain K, Mohapatra T, Das P, Misra MC, Gupta SD, Ghosh M, Kabra M, Bansal VK, Kumar S, Sreenivas V, Garg PK (2014) Sequential occurrence of preneoplastic lesions and accumulation of loss of heterozygosity in patients with gallbladder stones suggest causal association with gallbladder cancer. Ann. Surg. 260:1073–1080CrossRefPubMed
3.
Espinoza JA, Bizama C, García P, Ferreccio C, Javle M, Miquel JF, Koshiol J, Roa JC (2016) The inflammatory inception of gallbladder cancer. Biochim. Biophys. Acta 1865:245–254PubMedPubMedCentral
4.
Nakamura H, Arai Y, Totoki Y, Shirota T, Elzawahry A, Kato M, Hama N, Hosoda F, Urushidate T, Ohashi S, Hiraoka N, Ojima H, Shimada K, Okusaka T, Kosuge T, Miyagawa S, Shibata T (2015) Genomic spectra of biliary tract cancer. Nat. Genet. 47:1003–1010CrossRefPubMed
5.
Bastos-Rodrigues L, Pimenta JR, Pena SD (2006) The genetic structure of human populations studied through short insertion-deletion polymorphisms. Ann. Hum. Genet. 70:658–665CrossRefPubMed
6.
7.
Nagahashi M, Ajioka Y, Lang I, Szentirmay Z, Kasler M, Nakadaira H, Yokoyama N, Watanabe G, Nishikura K, Wakai T, Shirai Y, Hatakeyama K, Yamamoto M (2008) Genetic changes of p53, K-ras, and microsatellite instability in gallbladder carcinoma in high-incidence areas of Japan and Hungary. World J. Gastroenterol. 14:70–75CrossRefPubMedPubMedCentral
8.
Saetta AA (2006) K-ras, p53 mutations, and microsatellite instability (MSI) in gallbladder cancer. J. Surg. Oncol. 93:644–649CrossRefPubMed
9.
Hanada K, Tsuchida A, Iwao T, Eguchi N, Sasaki T, Morinaka K, Matsubara K, Kawasaki Y, Yamamoto S, Kajiyama G (1999) Gene mutations of K-ras in gallbladder mucosae and gallbladder carcinoma with an anomalous junction of the pancreaticobiliary duct. Am. J. Gastroenterol. 94:1638–1642CrossRefPubMed
10.
Bakos RM, Besch R, Zoratto GG, Godinho JM, Mazzotti NG, Ruzicka T, Bakos L, Santos SE, Ashton-Prolla P, Berking C, Giugliani R (2011) The CDKN2A p.A148T variant is associated with cutaneous melanoma in southern Brazil. Exp. Dermatol. 20:890–893CrossRefPubMed
11.
Soufir N, Ribojad M, Magnaldo T, Thibaudeau O, Delestaing G, Daya-Grosjean L, Rivet J, Sarasin A, Basset-Seguin N (2002) Germline and somatic mutations of the INK4a-ARF gene in a xeroderma pigmentosum group C patient. J Invest Dermatol 119:1355–1360CrossRefPubMed
Metadata
Title
Genetic Analysis of Brazilian Patients with Gallbladder Cancer
Authors
Cristina Sábato
Luciana Bastos-Rodrigues
Debora Chaves Moraes
Eitan Friedman
Luiz De Marco
Vivian Resende
Publication date
01-04-2019
Publisher
Springer Netherlands
Published in
Pathology & Oncology Research / Issue 2/2019
Print ISSN: 1219-4956
Electronic ISSN: 1532-2807
DOI
https://doi.org/10.1007/s12253-018-0407-7

Other articles of this Issue 2/2019

Pathology & Oncology Research 2/2019 Go to the issue

Original Article

Identification of Key Potential Targets and Pathway for Arsenic Trioxide by Systemic Bioinformatics Analysis in Pancreatic Cancer

Original Article

Expression of microRNA-150 and its Target Gene IGF2BP1 in Human Osteosarcoma and their Clinical Implications

Letter to the Editor

Early Skin Rash and Cetuximab-Based Therapy of Advanced Biliary Tract Cancer

Original Article

The Effect of CD86 Expression on the Proliferation and the Survival of CLL Cells

Letter to the Editor

Promoter Mutation Analysis of ALDOA Gene in Solid Tumors and Acute Leukemias

Letter to the Editor

The Diagnostic Dilemma of Epithelial Marker Expression in Glioblastoma
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits